Unknown

Dataset Information

0

PET-Based Human Dosimetry of 68Ga-NODAGA-Exendin-4, a Tracer for ?-Cell Imaging.


ABSTRACT: 68Ga-NODAGA-exendin-4 is a promising tracer for ?-cell imaging using PET/CT. Possible applications include preoperative visualization of insulinomas and discrimination between focal and diffuse forms of congenital hyperinsulinism. There is also a significant role for this tracer in extending our knowledge on the role of ?-cell mass in the pathophysiology of type 1 and type 2 diabetes by enabling noninvasive quantification of tracer uptake as a measure for ?-cell mass. Calculating radiation doses from this tracer is important to assess its safety for use in patients (including young children) with benign diseases and healthy individuals. Methods: Six patients with hyperinsulinemic hypoglycemia were included. After intravenous injection of 100 MBq of the tracer, 4 successive PET/CT scans were obtained at 30, 60, 120, and 240 min after injection. Tracer activity in the pancreas, kidneys, duodenum, and remainder of the body were determined, and time-integrated activity coefficients for the measured organs were calculated. OLINDA/EXM software, version 1.1, was applied to calculate radiation doses using the reference adult male and female models and to estimate radiation doses to children. Results: The mean total effective dose for adults was very low (0.71 ± 0.07 mSv for a standard injected dose of 100 MBq). The organ with the highest absorbed dose was the kidney (47.3 ± 10.2 mGy/100 MBq). The estimated effective dose was 2.32 ± 0.32 mSv for an injected dose of 20 MBq in newborns. This dose decreased to 0.77 ± 0.11 mSv/20 MBq for 1-y-old children and 0.59 ± 0.05 mSv for an injected dose of 30 MBq in 5-y-old children. Conclusion: Our human PET/CT-based dosimetric calculations show that the effective radiation doses from the novel tracer 68Ga-NODAGA-exendin-4 are very low for adults and children. The doses are lower than reported for other polypeptide tracers such as somatostatin analogs (2.1-2.6 mSv/100 MBq) and are beneficial for application as a research tool, especially when repeated examinations are needed.

SUBMITTER: Boss M 

PROVIDER: S-EPMC6954461 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

PET-Based Human Dosimetry of <sup>68</sup>Ga-NODAGA-Exendin-4, a Tracer for β-Cell Imaging.

Boss Marti M   Buitinga Mijke M   Jansen Tom J P TJP   Brom Maarten M   Visser Eric P EP   Gotthardt Martin M  

Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20190913 1


<sup>68</sup>Ga-NODAGA-exendin-4 is a promising tracer for β-cell imaging using PET/CT. Possible applications include preoperative visualization of insulinomas and discrimination between focal and diffuse forms of congenital hyperinsulinism. There is also a significant role for this tracer in extending our knowledge on the role of β-cell mass in the pathophysiology of type 1 and type 2 diabetes by enabling noninvasive quantification of tracer uptake as a measure for β-cell mass. Calculating radi  ...[more]

Similar Datasets

| S-EPMC8714834 | biostudies-literature
| S-EPMC7413240 | biostudies-literature
| S-EPMC7749060 | biostudies-literature
| S-EPMC8364589 | biostudies-literature
| S-EPMC8580011 | biostudies-literature
| S-EPMC8724897 | biostudies-literature
| S-EPMC7423886 | biostudies-literature
| S-EPMC8218160 | biostudies-literature
| S-EPMC7881688 | biostudies-literature
| S-EPMC7581659 | biostudies-literature